Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | TP53 | P04637 | 3/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1138627 | 0.87 | TSHR (0.45) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL28059039 | 0.86 | TSHR (0.38) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL8988187 | 0.86 | TSHR (0.38) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL9747219 | 0.85 | TSHR (0.37) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL4958343 | 0.85 | TSHR (0.37) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL2145660 | 0.85 | TSHR (0.44) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL1507509 | 0.85 | TSHR (0.40) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL19583244 | 0.84 | TSHR (0.38) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL2921941 | 0.83 | TSHR (0.42) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL10395627 | 0.83 | HCAR2 (0.43) | TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1027 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137844-A1 | MEDICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME | TERUMO KABUSHIKI KAISHA (JP) | 2026-05-21 | — | — | US | claimed |
| EP-4740974-A1 | MEDICAL INSTRUMENT AND MANUFACTURING METHOD THEREFOR | Terumo Kabushiki Kaisha (JP) | 2026-05-13 | — | — | EP | claimed |
| US-20260102544-A1 | MEDICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME | TERUMO KABUSHIKI KAISHA (JP) | 2026-04-16 | — | — | US | claimed |
| EP-4725515-A1 | MEDICAL INSTRUMENT AND PRODUCTION METHOD FOR SAME | Terumo Kabushiki Kaisha (JP) | 2026-04-15 | — | — | EP | claimed |
| US-20250289981-A1 | PRESSURE SENSITIVE ADHESIVES WITH STATIC PEEL RESISTANCE | SYNTHOMER DEUTSCHLAND GMBH (DE) | 2025-09-18 | — | — | US | claimed |
| US-20250206861-A1 | COPOLYMER FOR SUPPRESSING PROTEIN ADSORPTION, METHOD FOR PRODUCING COPOLYMER, RESIN MODIFIER, MOLDING MATERIAL, COPOLYMER-CONTAINING COMPOSITION, COATING FILM, AND ARTICLE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-06-26 | — | — | US | claimed |
| US-12264212-B2 | Copolymer for suppressing protein adsorption, method for producing copolymer, resin modifier, molding material, copolymer-containing composition, coating film, and article | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-04-01 | — | — | US | claimed |
| WO-2025018283-A1 | MEDICAL INSTRUMENT AND MANUFACTURING METHOD THEREFOR | テルモ株式会社 | 2025-01-23 | — | — | WO | claimed |
| EP-3858879-B1 | COPOLYMER FOR SUPPRESSING PROTEIN ADSORPTION, METHOD FOR PRODUCING COPOLYMER, RESIN MODIFIER, MOLDING MATERIAL, COPOLYMER-CONTAINING COMPOSITION, COATING FILM AND ARTICLE | MITSUBISHI CHEM CORP (JP) | 2025-01-01 | — | — | EP | claimed |
| WO-2024257760-A1 | MEDICAL INSTRUMENT AND PRODUCTION METHOD FOR SAME | テルモ株式会社 | 2024-12-19 | — | — | WO | claimed |
| US-5045422-A | Core-shell polymers, fluoropolymer core, pressure fixing, electrography | XEROX CORPORATION (US) | 1991-09-03 | — | — | US | claimed |
| US-5043240-A | Encapsulated toner compositions | XEROX CORPORATION (US) | 1991-08-27 | — | — | US | claimed |
| US-5035970-A | Encapsulated toner compositions and processes thereof | XEROX CORPORATION (US) | 1991-07-30 | — | — | US | claimed |
| US-5023159-A | Encapsulated electrophotographic toner compositions | XEROX CORPORATION (US) | 1991-06-11 | — | — | US | claimed |
| US-5013630-A | Encapsulated toner compositions | XEROX CORPORATION (US) | 1991-05-07 | — | — | US | claimed |
| EP-0425436-A2 | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof | CIBA-GEIGY AG (CH) | 1991-05-02 | — | — | EP | claimed |
| US-4985507-A | COPOLYMER OF ETHYLENE, ALKYL ACRYLATE, AND AN ALKOXYALKYL ACRYLATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-01-15 | — | — | US | claimed |
| US-4912186-A | Using alkyl acrylate, vinyl compounds in presence of free radical catalyst | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1990-03-27 | — | — | US | claimed |
| EP-0343525-A2 | Elastomer composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-11-29 | — | — | EP | claimed |
| EP-0290131-A2 | Acrylic rubber, acrylic rubber composition and cured rubber article thereof | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1988-11-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102544-A1 | MEDICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME | F9, F2, H1-0 | TSHR 1419/4885HPGD 991/4885ALDH1A1 3948/4885 |
| US-20260137844-A1 | MEDICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME | F2, FGB, F9 | TSHR 770/4885HPGD 371/4885ALDH1A1 2046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.